Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors

The purpose of this study was to retrospectively review the pathologic complete response (pCR) rate from patients (n=86) with stage II and III HER2-positive breast cancer treated with neoadjuvant chemotherapy at our institution from 2008 to 2013 and to determine possible predictive and prognostic fa...

全面介紹

Na minha lista:
書目詳細資料
發表在:Braz J Med Biol Res
Main Authors: Buzatto, I.P.C., Ribeiro-Silva, A., Andrade, J.M., Carrara, H.H.A., Silveira, W.A., Tiezzi, D.G.
格式: Artigo
語言:Inglês
出版: Associação Brasileira de Divulgação Científica 2017
主題:
Clinical Investigation
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5304215/
https://ncbi.nlm.nih.gov/pubmed/28146217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/1414-431X20165674
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍